1. Home
  2. IMUX vs KLXE Comparison

IMUX vs KLXE Comparison

Compare IMUX & KLXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMUX
  • KLXE
  • Stock Information
  • Founded
  • IMUX 2016
  • KLXE 2018
  • Country
  • IMUX United States
  • KLXE United States
  • Employees
  • IMUX N/A
  • KLXE N/A
  • Industry
  • IMUX Biotechnology: Pharmaceutical Preparations
  • KLXE Oilfield Services/Equipment
  • Sector
  • IMUX Health Care
  • KLXE Energy
  • Exchange
  • IMUX Nasdaq
  • KLXE Nasdaq
  • Market Cap
  • IMUX 86.3M
  • KLXE 83.1M
  • IPO Year
  • IMUX N/A
  • KLXE N/A
  • Fundamental
  • Price
  • IMUX $1.00
  • KLXE $4.71
  • Analyst Decision
  • IMUX Strong Buy
  • KLXE Hold
  • Analyst Count
  • IMUX 6
  • KLXE 1
  • Target Price
  • IMUX $12.67
  • KLXE $4.50
  • AVG Volume (30 Days)
  • IMUX 923.9K
  • KLXE 178.5K
  • Earning Date
  • IMUX 02-24-2025
  • KLXE 03-05-2025
  • Dividend Yield
  • IMUX N/A
  • KLXE N/A
  • EPS Growth
  • IMUX N/A
  • KLXE N/A
  • EPS
  • IMUX N/A
  • KLXE N/A
  • Revenue
  • IMUX N/A
  • KLXE $738,000,000.00
  • Revenue This Year
  • IMUX N/A
  • KLXE N/A
  • Revenue Next Year
  • IMUX N/A
  • KLXE $4.79
  • P/E Ratio
  • IMUX N/A
  • KLXE N/A
  • Revenue Growth
  • IMUX N/A
  • KLXE N/A
  • 52 Week Low
  • IMUX $0.92
  • KLXE $4.18
  • 52 Week High
  • IMUX $2.11
  • KLXE $9.48
  • Technical
  • Relative Strength Index (RSI)
  • IMUX 50.39
  • KLXE 39.05
  • Support Level
  • IMUX $0.92
  • KLXE $4.51
  • Resistance Level
  • IMUX $0.97
  • KLXE $5.12
  • Average True Range (ATR)
  • IMUX 0.06
  • KLXE 0.36
  • MACD
  • IMUX 0.01
  • KLXE -0.09
  • Stochastic Oscillator
  • IMUX 66.61
  • KLXE 12.12

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

Share on Social Networks: